CSIMarket Company Name, Ticker, Industry, else..
 
Genmab A  (NASDAQ: GMAB)
 
Price: $33.4300 $0.27 0.814%
Day's High: $33.66999816894531 Week Perf: -0.95 %
Day's Low: $ 33.25 30 Day Perf: 16.56 %
Volume (M): 573,883 52 Wk High: $ 35.43
Volume (M$): $ 0 52 Wk Avg: $29.38
Open: $33.33 52 Wk Low: $23.62



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 3,029
 Revenues (TTM) (Millions $) 4,645
 Net Income (TTM) (Millions $) 1,299
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Genmab operates in the pharmaceutical, biotechnology, and life sciences sectors. The company incorporates sustainable practices throughout its operations, with oversight from its Board of Directors and Executive Management. Genmab engages in risk management, stakeholder engagement, and sustainability reporting in accordance with recognized frameworks.


   Company Address: Carl Jacobsens Vej 30 Valby 2500
   Company Phone Number: 7020 2728   Stock Exchange / Ticker: NASDAQ GMAB


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 43.39
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.34
Working Capital Ratio 0.37
Leverage Ratio (MRQ) 1.2
Total Debt to Equity 0.86
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.47

Per Share Current
Earnings (TTM) 0.77 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash -
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 1,533,509
Net Income per Employee (TTM) 428,854
Receivable Turnover Ratio (TTM) 1231.7
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.65

Profitability Ratios Current
Gross Margin (MRQ) 93.6 %
Operating Margin (MRQ) 28.63 %
Net Margin (MRQ) 25.89 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 20.04 %

Management Effectiveness Current
Return On Assets (TTM) 18.05 %
Return On Investment (TTM) 28.87 %
Return On Equity (TTM) 38.63 %
Dividend Yield -
Pay out Ratio (TTM) -



Genmab A's Segments
DARZALEX    65.67 % of total Revenue
Kesimpta    11.91 % of total Revenue
TEPEZZA    2.82 % of total Revenue
Other    0.59 % of total Revenue
Janssen    68.95 % of total Revenue
AbbVie    1.77 % of total Revenue
Roche    2.85 % of total Revenue
Novartis    11.99 % of total Revenue
BioNTech    1.08 % of total Revenue
Pfizer    2.07 % of total Revenue
Royalties    83.39 % of total Revenue
Net product Sales    10.7 % of total Revenue
Reimbursement revenue    1.42 % of total Revenue
Milestone revenue    2.61 % of total Revenue
Collaboration revenue    1.88 % of total Revenue
Excluding net product Sales    89.3 % of total Revenue
Denmark    89.41 % of total Revenue
Netherlands    0.03 % of total Revenue
United States    4.84 % of total Revenue
Japan    5.73 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.